Mehrdad Arjomandi
-
- Air Quality and Health Impacts 25
- Climate Change and Health Impacts 18
- Physiology top 10%
- Asthma and respiratory diseases 11
- Sarcoidosis and Beryllium Toxicity Research 4
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 29
- Respiratory Support and Mechanisms 8
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Lung Cancer Diagnosis and Treatment 4
- Pharmacology top 10%
- Co-authors
- John R. BalmesNina HollandIra B. TagerConnie L. ChenQing LiuXiaoli TianDaisuke MaruyamaArun Prakash
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Mehrdad Arjomandi
74 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 138
- Health, Toxicology and Mutagenesis 455
- Physiology 286
- Pulmonary and Respiratory Medicine 301
- Pharmacology 148
- Chemical Health and Safety 5
Countries citing papers authored by Mehrdad Arjomandi
This map shows the geographic impact of Mehrdad Arjomandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Arjomandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Arjomandi more than expected).
Fields of papers citing papers by Mehrdad Arjomandi
This network shows the impact of papers produced by Mehrdad Arjomandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Arjomandi. The network helps show where Mehrdad Arjomandi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehrdad Arjomandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 97 | |
| 13 | 2021 | 14 | |
| 14 | 2020 | 8 | |
| 15 | 2017 | 48 | |
| 16 | 2015 | 25 | |
| 17 | Efficacy of Prophylactic Intravenous Dexamethasone in | 2012 | 1 |
| 18 | Designing a Minimum Data Set for Breast Cancer: a Starting Point for Breast Cancer Registration in Iran | 2012 | 6 |
| 19 | 2010 | 9 | |
| 20 | 2005 | 47 |
About Mehrdad Arjomandi
Mehrdad Arjomandi is a scholar working on Health, Toxicology and Mutagenesis, Issues, ethics and legal aspects and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Air Quality and Health Impacts (25 papers), Climate Change and Health Impacts (18 papers), Asthma and respiratory diseases (11 papers), Respiratory Support and Mechanisms (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (455 citations), Physiology (286 citations) and Pulmonary and Respiratory Medicine (301 citations). Mehrdad Arjomandi has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include John R. Balmes, Nina Holland, Ira B. Tager, Connie L. Chen, Qing Liu, Xiaoli Tian, Daisuke Maruyama, Arun Prakash, Hofer Wong and Mark W. Frampton. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.